Previous 10 | Next 10 |
Allakos (NASDAQ: ALLK ) resumed with Neutral rating and $94 (27% upside) at Goldman Sachs. More news on: Incyte Corporation, National Vision Holdings, Inc., Tandem Diabetes Care, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
BOSTON, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors and whistleblowers nationwide, reminds investors of the Firm’s ongoing investigations of Allakos, Inc . and Sterling Bancorp, Inc. The inve...
Biotech Pulse The biotech group closed 2019 with its longest rally of the year. It was a welcome change from what had mostly been an uphill battle. While the broader market was sailing from one high to another, biotechs and pharmaceuticals (biopharma) were still marking their 2019 lows in ea...
Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of Allakos Inc. (“Allakos” or the “Company”) (NASDAQ: ALLK ) investors concerning the Company and its officers’ possible violations of federal securities laws. I...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Allakos Inc. (“Allakos” or the “Company”) (NASDAQ: ALLK ) investors concerning the Company and its officers’ possible violations of federal securities laws. If...
BOSTON, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors and whistleblowers nationwide, is investigating Allakos, Inc. (NASDAQ: ALLK) and certain of its officers and directors for potential violations of fe...
Gainers: Inpixon (NASDAQ: INPX ) +68% . More news on: Inpixon, Mirum Pharmaceuticals, Inc., YayYo, Inc., Stocks on the move, Read more ...
Allakos ( ALLK ) was up a whopping 40% in a day's trading on 8x surge in volume on Friday on what has been called "sales chatter." I covered ALLK in August in a mostly bearish article after it almost tripled overnight after results from a Phase 2 study of lead candidate AK002 was publis...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
News, Short Squeeze, Breakout and More Instantly...
– AK006 achieved serum concentrations consistent with levels demonstrating inhibitory activity in preclinical experiments – – Skin biopsies from subjects treated with AK006 show high receptor occupancy – – AK006 was well-tolerated with a favorable safety pro...
– Top-line Phase 1 CSU results expected at year end 2024 – SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing AK006 for the treatment of mast cell-driven diseases, today announced that the first patient with chr...
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for...